Evidence map›Paper›PMID 35718965›Full record

ReviewCurrent Alzheimer research2022

Gastrointestinal Changes and Alzheimer's Disease.

Mona Sohrabi, Bijayani Sahu, Harpreet Kaur, Wendie A Hasler, Atish Prakash, Colin K Combs

Open access · greenAbstract readReview
In one paragraph

Review in Current Alzheimer research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Gut bacteria: an etiological agent in human pathological conditions.Frontiers in cellular and infection microbiology · 2024
    Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mona SohrabiDepartment of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202-9037, USA.
Bijayani SahuDepartment of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202-9037, USA.
Harpreet KaurDepartment of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202-9037, USA.
Wendie A HaslerDepartment of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202-9037, USA.
Atish PrakashDepartment of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202-9037, USA.
Colin K CombsDepartment of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58202-9037, USA.
University of North Dakota · US

Funding

Research CoresP20GM103442 · NIGMS · UNIVERSITY OF NORTH DAKOTA · PI Donald A. Sens · 2012 to 2026
$53.0M
Tracking and Evaluation CoreU54GM128729 · NIGMS · UNIVERSITY OF NORTH DAKOTA · PI BASSON, MARC D. · 2018 to 2022
$20.3M
Yersina perstis interactions with macrophagesP20GM113123 · NIGMS · UNIVERSITY OF NORTH DAKOTA · PI COMBS, COLIN K · 2016 to 2025
$19.9M
Validation of Adenylosuccinate as a Novel Endogenous Pro-Angiogenic Factor in the BrainR01NS119279 · NINDS · UNIVERSITY OF NORTH DAKOTA · PI GOLOVKO, MIKHAIL Y · 2021 to 2025
$2.7M
Communicating Intestinal Inflammation to the Brain in Alzheimer's DiseaseRF1AG069378 · NIA · UNIVERSITY OF NORTH DAKOTA · PI COMBS, COLIN K · 2020 to 2022
$1.6M
Brain-Gut Communication in Alzheimer's DiseaseR01AG048993 · NIA · UNIVERSITY OF NORTH DAKOTA · PI COMBS, COLIN K · 2015 to 2019
$1.4M
APP Regulates Brain and Adipose Changes in ObesityR01AG042819 · NIA · UNIVERSITY OF NORTH DAKOTA · PI COMBS, COLIN K, GOLOVKO, MIKHAIL Y · 2012 to 2016
$1.4M
Oral Cavity and Brain Cross-talk in Alzheimer's DiseaseRF1AG072727 · NIA · UNIVERSITY OF NORTH DAKOTA · PI COMBS, COLIN K · 2021 to 2021
$1.2M
NIA NIH HHS R01 AG042819NIA NIH HHS R01 AG048993NIA NIH HHS RF1 AG069378NIA NIH HHS RF1 AG072727NIGMS NIH HHS P20 GM103442NIGMS NIH HHS P20 GM113123NIGMS NIH HHS U54 GM128729NINDS NIH HHS R01 NS119279
6 · The paper itself

Abstract

backgroundThere is a well-described mechanism of communication between the brain and gastrointestinal system in which both organs influence the function of the other. This bi-directional communication suggests that disease in either organ may affect function in the other.

objectiveTo assess whether the evidence supports gastrointestinal system inflammatory or degenerative pathophysiology as a characteristic of Alzheimer's disease (AD).

methodsA review of both rodent and human studies implicating gastrointestinal changes in AD was performed.

resultsNumerous studies indicate that AD changes are not unique to the brain but also occur at various levels of the gastrointestinal tract involving both immune and neuronal changes. In addition, it appears that numerous conditions and diseases affecting regions of the tract may communicate to the brain to influence disease.

conclusionGastrointestinal changes represent an overlooked aspect of AD, representing a more system influence of this disease.

Indexed as

Alzheimer DiseaseBrainGastrointestinal TractHumansNeuronsAlzheimeramyloidenteric neuroninflammationintestineMicrobiome

Identifiers

PMID35718965
PMCPMC10497313
OpenAlexW4283167693

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.